Evidence map›Paper›PMID 32391273›Full record

SynthesisFrontiers in oncology2020

A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs.

Elizabeth Pan, David Bogumil, Victoria Cortessis, Sherrie Yu, Jorge Nieva

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. The Fingerprints of Biomedical Science in Internal Medicine.Advances in experimental medicine and biology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Elizabeth PanDepartment of Medical Oncology, Norris Comprehensive Cancer Center, Los Angeles, CA, United States.
David BogumilDepartment of Epidemiology, University of Southern California, Los Angeles, CA, United States.
Victoria CortessisDepartment of Preventative Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA, United States.
Sherrie YuDepartment of Medical Oncology, Norris Comprehensive Cancer Center, Los Angeles, CA, United States.
Jorge NievaDepartment of Medical Oncology, Norris Comprehensive Cancer Center, Los Angeles, CA, United States.
USC Norris Comprehensive Cancer Center · USUniversity of Southern California · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
NCI NIH HHS P30 CA014089
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell modelslung cancerlung cancer therapiesmouse modelspreclinical studies

Identifiers

PMID32391273
PMCPMC7190806
OpenAlexW3019543925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.